8-K//Current report
Apellis Pharmaceuticals, Inc. 8-K
Accession 0001193125-25-086304
$APLSCIK 0001492422operating
Filed
Apr 20, 8:00 PM ET
Accepted
Apr 21, 7:11 AM ET
Size
146.8 KB
Accession
0001193125-25-086304
Documents
- 8-Kd918674d8k.htmPrimary
8-K
- EX-101.SCHapls-20250417.xsd
XBRL TAXONOMY EXTENSION SCHEMA
- EX-101.LABapls-20250417_lab.xml
XBRL TAXONOMY EXTENSION LABEL LINKBASE
- EX-101.PREapls-20250417_pre.xml
XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE
- XMLR1.htm
IDEA: XBRL DOCUMENT
- EXCELFinancial_Report.xlsx
IDEA: XBRL DOCUMENT
- XMLShow.js
IDEA: XBRL DOCUMENT
- XMLreport.css
IDEA: XBRL DOCUMENT
- XMLFilingSummary.xml
IDEA: XBRL DOCUMENT
- JSONMetaLinks.json
IDEA: XBRL DOCUMENT
- ZIP0001193125-25-086304-xbrl.zip
IDEA: XBRL DOCUMENT
- XMLd918674d8k_htm.xml
IDEA: XBRL DOCUMENT
Issuer
Apellis Pharmaceuticals, Inc.
CIK 0001492422
Entity typeoperating
IncorporatedDE
Related Parties
1- filerCIK 0001492422
Filing Metadata
- Form type
- 8-K
- Filed
- Apr 20, 8:00 PM ET
- Accepted
- Apr 21, 7:11 AM ET
- Size
- 146.8 KB